<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30102">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02714829</url>
  </required_header>
  <id_info>
    <org_study_id>ExcelOS 14-01</org_study_id>
    <nct_id>NCT02714829</nct_id>
  </id_info>
  <brief_title>Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioAlpha Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioAlpha Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Randomized, Subject-Assessor Blind, Multi-center, Clinical Study of Injectable Ceramics
      Bone Graft Substitute Containing rhBMP-2
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>March 2016</start_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compared the changed height and standard height by computed tomography.</measure>
    <time_frame>at 12 weeks after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Alveolar Bone Preservation</condition>
  <condition>Bone Graft</condition>
  <arm_group>
    <arm_group_label>Inject BMP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ExcelOS Inject / rhBMP-2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ExcelOS Inject</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ExcelOS Inject</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inject BMP</intervention_name>
    <arm_group_label>Inject BMP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ExcelOS Inject</intervention_name>
    <arm_group_label>ExcelOS Inject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons without periodontal disease

        Exclusion Criteria:

          -  Women who are pregnant or plan to be pregnant within study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 21, 2016</lastchanged_date>
  <firstreceived_date>March 8, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Injectable Ceramics Bone Graft Substitute Containing rhBMP-2</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
